FINWIRES · TerminalLIVE
FINWIRES

Inpex's Profit Slides 13% in Q1

By

Inpex's (TYO:1605) profit attributable to owners of the parent fell 13% to 109.4 billion yen in the first quarter from 126.3 billion yen a year earlier, according to a Tokyo bourse filing on Wednesday.

Japan's largest oil and gas exploration company's earnings per share decreased to 94 yen from 105.38 yen a year ago.

Revenue dropped 6.5% to 501.8 billion yen in Q1 from 536.9 billion yen in the prior-year period.

Inpex raised its earnings forecast for 2026, citing stable operations at the Ichthys Project and updated assumptions for crude oil prices and exchange rates from the second quarter onward.

The company now expects attributable profit of between 350 billion and 450 billion yen from 330 billion yen initially, basic EPS of between 300.95 yen and 386.94 yen from 283.17 yen, and revenue of between 2.004 trillion and 2.291 trillion yen from 1.893 trillion yen.

Inpex plans to pay interim and year-end dividends of 54 yen per share each for the year, which is higher than amount paid in the year-ago period.

Related Articles

Asia

Refex Industries Secures Supply Order Worth INR365 Million

Refex Industries (NSE:REFEX, BOM:532884) received an order worth 365 million Indian rupees from a Navratna public sector steel company for supply of bulk industrial commodity, according to a Wednesday filing.The order is to be executed within 40 days, the filing said.

$BOM:532884$NSE:REFEX
Asia

Zaggle Prepaid Ocean Services Names New Group CFO; Interim CFO to Step Down

Zaggle Prepaid Ocean Services (NSE:ZAGGLE, BOM:543985) appointed Venkatesh Ramachandran as group chief financial officer, effective May 18, according to a Wednesday filing on Indian bourses.Following the appointment, Rajesh Tummalaganti will cease to be interim CFO, effective May 17, the company said. He will continue as deputy chief financial officer, it added.

$BOM:543985$NSE:ZAGGLE
Asia

Smruthi Organics Clocks Sharp Decline in Fiscal Q4 Net Profit

Smruthi Organics' (BOM:540686) net profit more than halved to 10.7 million Indian rupees in the fiscal fourth quarter from 22.3 million rupees a year earlier, according to an Indian bourse filing on Wednesday.Earnings per share for the quarter ended March 31 contracted to 0.93 rupees from 1.95 rupees a year ago.The pharmaceutical company's revenue slipped year-on-year to 290.9 million rupees from 380.9 million rupees, the filing said.The company's board recommended a dividend of 1.5 rupees per share for fiscal 2026 ended March 31.Shares of the company were up 4% in after-market hours.

$BOM:540686